Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues

M Obulesu, MJ Lakshmi - Neurochemical research, 2014 - Springer
Alzheimer's disease (AD) is a devastative neurodegenerative disorder with complex
etiology. Apoptosis, a biological process that plays an essential role in normal physiology to …

[HTML][HTML] Modifications and trafficking of APP in the pathogenesis of Alzheimer's disease

X Wang, X Zhou, G Li, Y Zhang, Y Wu… - Frontiers in molecular …, 2017 - frontiersin.org
Alzheimer's disease (AD), the most common neurodegenerative disorder, is the leading
cause of dementia. Neuritic plaque, one of the major characteristics of AD neuropathology …

[HTML][HTML] Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets

A Izzo, N Mollo, M Nitti, S Paladino, G Calì… - Molecular …, 2018 - Springer
Abstract Trisomy of chromosome 21 (TS21) is the most common autosomal aneuploidy
compatible with postnatal survival with a prevalence of 1 in 700 newborns. Its phenotype is …

Neurogenesis impairment: An early developmental defect in Down syndrome

F Stagni, A Giacomini, M Emili, S Guidi… - Free Radical Biology and …, 2018 - Elsevier
Down syndrome (DS) is characterized by brain hypotrophy and intellectual disability starting
from early life stages. Accumulating evidence shows that the phenotypic features of the DS …

[HTML][HTML] A review of oxidative stress products and related genes in early Alzheimer's disease

F Cioffi, RHI Adam, R Bansal… - Journal of Alzheimer's …, 2021 - content.iospress.com
Oxidative stress is associated with the progression of Alzheimer's disease (AD). Reactive
oxygen species can modify lipids, DNA, RNA, and proteins in the brain. The products of their …

APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate Alzheimer's pathology in trisomy 21 neurons

CI Wu, EA Vinton, RV Pearse, K Heo, AJ Aylward… - Molecular …, 2022 - nature.com
Abstract Trisomy 21 (T21) causes Down syndrome and an early-onset form of Alzheimer's
disease (AD). Here, we used human induced pluripotent stem cells (hiPSCs) along with …

Dendrimer architectonics to treat cancer and neurodegenerative diseases with implications in theranostics and personalized medicine

H Moorthy, T Govindaraju - ACS Applied Bio Materials, 2021 - ACS Publications
Integration of diagnostic and therapeutic functions in a single platform namely theranostics
has become a cornerstone for personalized medicine. Theranostics platform facilitates …

[HTML][HTML] Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice

A Majer, SJ Medina, Y Niu, B Abrenica… - PLoS …, 2012 - journals.plos.org
Prion diseases typically have long pre-clinical incubation periods during which time the
infectious prion particle and infectivity steadily propagate in the brain. Abnormal neuritic …

Nonapoptotic caspases in neural development and in anesthesia-induced neurotoxicity

N Sarić, K Hashimoto-Torii, V Jevtović-Todorović… - Trends in …, 2022 - cell.com
Apoptosis, classically initiated by caspase pathway activation, plays a prominent role during
normal brain development as well as in neurodegeneration. The noncanonical, nonlethal …

[HTML][HTML] High glucose promotes Aβ production by inhibiting APP degradation

Y Yang, Y Wu, S Zhang, W Song - PloS one, 2013 - journals.plos.org
Abnormal deposition of neuriticplaques is the uniqueneuropathological hallmark of
Alzheimer's disease (AD). Amyloid β protein (Aβ), the major component of plaques, is …